Hospitals, Formulations Brand, Diagnostics, and others

Posted On: 02 / May / 2023
2 346

Deal Details

Annual

Deal Type

Buy (Investor)
Maximum Loan

Industry

Hospital / Health Care
Charge

Deal Status

Active

Deal Description

  • Ticket Size = INR 200 Cr to 300 Cr
  • Formulation Companies should have good brand portfolio (Individual Brands / Portfolios). ARR for each brand should be INR 30 Cr to 40 Cr.
  • Niche Diagnostic Businesses such as Radiology, Molecular Diagnostic, etc., Orphan Drugs Assets (Rare Disease). Must have atleast cl,pleted Phase 2.
  • Established Brands outside India belonging to MNCs.
  • Anything in Health & Wellness Side.
  • Hospital in India (preferably Gujrat) and USA.

No Files Attached

Deal Value
200 Crore
Targeted Region
Asia Pacific

Revenue

2019-20
Undisclosed
2020-21
Undisclosed
2021-22
Undisclosed